GSK plc banner

Intrinsic Value

Not Available for GS71

There is not enough data to reliably calculate the intrinsic value for GSK plc.

Do our valuations actually work? See backtest results .

Alternatives to GS71

Fundamental Analysis

What GSK Does

Pharmaceuticals Health Care

In the heart of the pharmaceutical landscape, GSK plc stands as a venerable institution that intertwines scientific discovery with patient well-being. Originally founded as GlaxoSmithKline, the company has navigated the evolving demands of healthcare with a deft blend of innovation and strategic acumen. As a major player in the global healthcare sector, GSK operates within three principal segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.

Headquarters
United Kingdom UK
Employees
90 096
IPO date
May 22, 1972
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · October 28, 2026

GSK reiterated its 2026 outlook as specialty medicines drove momentum, the late-stage pipeline accelerated and restructuring moved ahead.

Open the earnings call
EPS
€0.44
Expected
€0.51
Surprise
−13.2%
Stock, next trading day
−0.6%
View Earnings Call

Past 12 months

Continue GS71 Research

Decided on GSK? Get an email when GS71 reaches the price you’d buy at. Free with an account.

Back to Top